Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trialNienke M. Scheltema(University Medical Center Utrecht), Louis Bont(University Medical Center Utrecht)The Lancet Respiratory MedicineFebruary 27, 201810.1016/s2213-2600(18)30055-9Cited by 186SaveCiteExport RISWatch citationsRelated PapersGlobal, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study|The Lancet|2017|2.4kIdentifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries|Frontiers in Pediatrics|2022|27